Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 7/20 | 0.38 |
| ▸ | PPARG | P37231 | 6/20 | 0.38 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.36 |
| ▸ | PPARD | Q03181 | 1/20 | 0.36 |
| ▸ | PCSK9 | Q8NBP7 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.34 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.34 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.34 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.33 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3844889 | 0.92 | PPARA (0.42) | PPARAPPARGKCNH2PPARDPCSK9 | |
| SCHEMBL3287502 | 0.91 | PPARA (0.48) | PPARAPPARGKCNH2PPARDPCSK9 | |
| SCHEMBL3840826 | 0.90 | PPARA (0.44) | PPARAPPARGKCNH2PPARDPCSK9 | |
| SCHEMBL3841118 | 0.90 | PPARA (0.40) | PPARAPPARGKCNH2PPARDPCSK9 | |
| SCHEMBL3844300 | 0.88 | PPARA (0.47) | PPARAPPARGKCNH2PPARDPCSK9 | |
| SCHEMBL3842289 | 0.88 | PPARG (0.39) | PPARAPPARGKCNH2PPARDPCSK9 | |
| SCHEMBL3844910 | 0.86 | PPARA (0.41) | PPARAPPARGKCNH2PPARDPCSK9 | |
| SCHEMBL3842928 | 0.86 | PPARA (0.42) | PPARAPPARGKCNH2PPARDPCSK9 | |
| SCHEMBL3843436 | 0.86 | PPARA (0.46) | PPARAPPARGKCNH2PPARDPCSK9 | |
| SCHEMBL3284607 | 0.85 | PPARA (0.41) | PPARAPPARGKCNH2PPARDPCSK9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1856065-B1 | 1,2,4-TRIAZINE DERIVATIVES, PREPARATION AND USE THEREOF IN HUMAN THERAPY | PF MEDICAMENT (FR) | 2009-11-11 | — | — | EP | claimed |